![Juan Sanchez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Juan Sanchez
Directeur/Membre du Conseil chez
NUVECTIS PHARMA, INC.
Fortune : 2 M $ au 30/06/2026
Profil
Juan F.
Sanchez is the founder of Intra-Cellular Therapies, Inc. Dr. Sanchez is currently an Independent Director at Nuvectis Pharma, Inc. since 2025.
Former jobs include Principal at Bristol Myers Squibb Co., Research Analyst at Punk Ziegel & Co., Vice President and Vice President-Healthcare Equity Research at Ladenburg Thalmann & Co., Inc. (Broker) from 2008 to 2014, and VP-Communications & Investor Relations at Intra-Cellular Therapies, Inc. Education includes a doctorate from Pontificia Universidad Javeriana in 1994, an MBA from Universidad de Los Andes in 1999, and a graduate degree from The Trustees of Columbia University in The City of New York in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 0,43 % | 11/06/2026 | 113 795 ( 0,43 % ) | 2 M $ | 30/06/2026 |
Postes actifs de Juan Sanchez
| Sociétés | Poste | Début |
|---|---|---|
| NUVECTIS PHARMA, INC. | Directeur/Membre du Conseil | 25/09/2025 |
Anciens postes connus de Juan Sanchez
| Sociétés | Poste | Fin |
|---|---|---|
Ladenburg Thalmann & Co., Inc. (Broker)
 Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2014 |
Ladenburg Thalmann & Co., Inc.
 Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | 01/01/2014 |
Punk Ziegel & Co.
 Punk Ziegel & Co. Investment Banks/BrokersFinance Provides broker dealer services, investment banking and research services | Analyst-Equity | 01/05/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2003 |
| INTRA-CELLULAR THERAPIES, INC. | Fondateur | - |
Formation de Juan Sanchez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Punk Ziegel & Co.
Punk Ziegel & Co. Investment Banks/BrokersFinance Provides broker dealer services, investment banking and research services | Finance |
Ladenburg Thalmann & Co., Inc. (Broker)
Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Universidad de Los Andes
 Universidad de Los Andes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pontificia Universidad Javeriana
 Pontificia Universidad Javeriana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Choisissez Zonebourse 
